GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin RisesZacks Investment Research • 07/30/25
Compared to Estimates, GE HealthCare (GEHC) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 07/30/25
GE HealthCare Technologies (GEHC) Q2 Earnings and Revenues Top EstimatesZacks Investment Research • 07/30/25
GE HealthCare launches new advanced digital X-ray system to enable access and increase efficiency in high throughput settingsBusiness Wire • 07/24/25
GE HealthCare drives growth with investment in AI-enabled medical devices and tops FDA's list of AI authorizations for 4th Year with 100Business Wire • 07/23/25
GEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded IndicationsZacks Investment Research • 06/25/25
FDA Approves Expanded Indications for GE HealthCare's Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer's PatientsBusiness Wire • 06/24/25
GE HealthCare's Flyrcado Sets New Benchmark in Cardiac PET ImagingZacks Investment Research • 06/24/25
GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025Business Wire • 06/23/25
GE Healthcare: Near-Term Margin Headwinds Priced In, Long-Term Growth Driven By New Products And M&AsSeeking Alpha • 06/22/25
GE HealthCare drives innovation in theranostics with latest technological advancesBusiness Wire • 06/21/25
Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford MedicineBusiness Wire • 06/19/25